A citation-based method for searching scientific literature

Mikhail Binnewies, Edward W Roberts, Kelly Kersten, Vincent Chan, Douglas F Fearon, Miriam Merad, Lisa M Coussens, Dmitry I Gabrilovich, Suzanne Ostrand-Rosenberg, Catherine C Hedrick, Robert H Vonderheide, Mikael J Pittet, Rakesh K Jain, Weiping Zou, T Kevin Howcroft, Elisa C Woodhouse, Robert A Weinberg, Matthew F Krummel. Nat Med 2018
Times Cited: 1201



Stefani Spranger, Thomas F Gajewski. Nat Rev Cancer 2018
Times Cited: 248




List of shared articles



Times cited

Nano-immunotherapy: Overcoming tumour immune evasion.
Maria L Guevara, Francesca Persano, Stefano Persano. Semin Cancer Biol 2021
11

Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer.
Shuang Zhang, Sonia Iyer, Hao Ran, Igor Dolgalev, Shengqing Gu, Wei Wei, Connor J R Foster, Cynthia A Loomis, Narciso Olvera, Fanny Dao,[...]. Cancer Discov 2021
8

Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer.
Jinyang Li, Salina Yuan, Robert J Norgard, Fangxue Yan, Yu H Sun, Il-Kyu Kim, Allyson J Merrell, Yogev Sela, Yanqing Jiang, Natarajan V Bhanu,[...]. Cancer Discov 2021
13

Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy.
Morgan E Lorkowski, Prabhani U Atukorale, Ketan B Ghaghada, Efstathios Karathanasis. Adv Healthc Mater 2021
2

Intratumoral heterogeneity in cancer progression and response to immunotherapy.
Ilio Vitale, Efrat Shema, Sherene Loi, Lorenzo Galluzzi. Nat Med 2021
33

Promises and challenges of adoptive T-cell therapies for solid tumours.
Matteo Morotti, Ashwag Albukhari, Abdulkhaliq Alsaadi, Mara Artibani, James D Brenton, Stuart M Curbishley, Tao Dong, Michael L Dustin, Zhiyuan Hu, Nicholas McGranahan,[...]. Br J Cancer 2021
5